News und Analysen
3 Dividend Stocks That Thrive in Bear Markets
One of the benefits of dividend investing is the comfort that comes from the regular income stream. But market downturns can many times throw that sense of security out the window. What income....
3 Dividend Stocks That Thrive in Bear Markets
One of the benefits of dividend investing is the comfort that comes from the regular income stream. But market downturns can many times throw that sense of security out the window. What income....
Why bluebird bio Inc Continued Its March Higher Again Today
Shares of bluebird bio (NASDAQ: BLUE) continued their seemingly unstoppable march higher this week, jumping another 10.8% today as of 2:58 p.m. EDT after two analysts increased their price targets....
Why bluebird bio Inc Continued Its March Higher Again Today
Shares of bluebird bio (NASDAQ: BLUE) continued their seemingly unstoppable march higher this week, jumping another 10.8% today as of 2:58 p.m. EDT after two analysts increased their price targets....
Why bluebird bio Inc Continued Its March Higher Again Today
Shares of bluebird bio (NASDAQ: BLUE) continued their seemingly unstoppable march higher this week, jumping another 10.8% today as of 2:58 p.m. EDT after two analysts increased their price targets....
Could Gilead Sciences Stock Skyrocket 25%? 1 Analyst Thinks So
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Could Gilead Sciences Stock Skyrocket 25%? 1 Analyst Thinks So
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Could Gilead Sciences Stock Skyrocket 25%? 1 Analyst Thinks So
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
BASTIDE : Chiffre d'affaires annuel : 218 M EUR en croissance de près de 14%
En K€
2015-2016
2016-2017
Croissance
Chiffre d'affaires 4ème trimestre
48 901
55 638
+13,8%
Chiffre d'affaires annuel
191 850
218 033
+ 13,7%
Le....
Found: 3 Stocks Retirees Should Consider Adding
In the hunt for stocks to carry you through your retirement, you're probably looking for low-volatility stocks that supply reliable, steadily rising streams of income. You're past the time....
Found: 3 Stocks Retirees Should Consider Adding
In the hunt for stocks to carry you through your retirement, you're probably looking for low-volatility stocks that supply reliable, steadily rising streams of income. You're past the time....
Why Investors Bid Immunogen Inc. Up Almost 12% Today
News that Irish biotech Jazz Pharmaceuticals (NASDAQ: JAZZ) had signed on to collaborate with Immunogen Inc. (NASDAQ: IMGN) in the development of drugs in the smaller, Massachusetts-based....
Why bluebird bio Inc Jumped Higher Today
bluebird bio (NASDAQ: BLUE) is up 10.1% at 3:40 p.m. EDT after Novartis (NYSE: NVS) got its chimeric antigen receptor T-cell (CAR-T) therapy Kymriah approved by the Food and Drug Administration....
Why Tiny Organovo Is Giving Money to Huge Biotech Amgen
In the first half of 2017, Amgen (NASDAQ: AMGN) paid out 140 times more in dividends to its shareholders than Organovo Holdings (NASDAQ: ONVO) made in revenue -- during its entire history as a....
Why Tiny Organovo Is Giving Money to Huge Biotech Amgen
In the first half of 2017, Amgen (NASDAQ: AMGN) paid out 140 times more in dividends to its shareholders than Organovo Holdings (NASDAQ: ONVO) made in revenue -- during its entire history as a....
Why Tiny Organovo Is Giving Money to Huge Biotech Amgen
In the first half of 2017, Amgen (NASDAQ: AMGN) paid out 140 times more in dividends to its shareholders than Organovo Holdings (NASDAQ: ONVO) made in revenue -- during its entire history as a....
Here's Why the Market Is Eviscerating Otonomy Inc. Stock Today
Otonomy Inc. (NASDAQ: OTIC) stock cratered Wednesday morning after the biotech and biopharmaceuticals company announced truly dismal results from a pivotal Phase 3 trial for its steroid candidate....
The Only Marijuana Stock to Rise by More Than 10% Last Week
The marijuana industry is growing like a weed, and it's been putting smiles on the faces of marijuana stock investors. Of the one dozen largest marijuana stocks by market cap, a vast majority are....
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Once upon a time, Gilead Sciences (NASDAQ: GILD) was one of the hottest biotech stocks on the market. But for most of the last two years, Gilead was anything but hot, with its market cap losing....
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Once upon a time, Gilead Sciences (NASDAQ: GILD) was one of the hottest biotech stocks on the market. But for most of the last two years, Gilead was anything but hot, with its market cap losing....
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Once upon a time, Gilead Sciences (NASDAQ: GILD) was one of the hottest biotech stocks on the market. But for most of the last two years, Gilead was anything but hot, with its market cap losing....
Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today
Shares of Abeona Therapeutics (NASDAQ: ABEO) jumped 18.4% on Tuesday, while shares of Sangamo Therapeutics (NASDAQ: SGMO) ended up 11.3%. The former is clearly because Abeona received a....
Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today
Shares of Abeona Therapeutics (NASDAQ: ABEO) jumped 18.4% on Tuesday, while shares of Sangamo Therapeutics (NASDAQ: SGMO) ended up 11.3%. The former is clearly because Abeona received a....
Here's Why AVEO Pharmaceuticals Lost as Much as 19% Today
Shares of biopharma AVEO Pharmaceuticals (NASDAQ: AVEO) sank 19% Tuesday after investors had more time to digest Monday's news. That was, the company announced that the drug Fotivda gained....
Why Movado Group, Catalent, and ImmunoGen Jumped Today
The stock market slowly climbed over the course of Tuesday's session as geopolitical events and the continuing aftermath of Hurricane Harvey dominated headlines. Investors were initially rattled....